Millions of People Will Soon Be Blindsided. Will You Be One of Them?

On April 20 at 7 p.m. ET, Louis Navellier and Matt McCall will reveal an event that’s about to rock the stock market and how you could use it to beat the markets by nearly 11X.

Tue, April 20 at 7:00PM ET

4 Medical Devices Stocks to Sell Now

The overall ratings of four Medical Devices stocks are down on Portfolio Grader this week. Each of these rates a “D” (“sell”) or “F” overall (“strong sell”).

This week, Volcano (NASDAQ:VOLC) falls to a D (“sell”), worse than last week’s grade of C (“hold”). Volcano designs, develops, manufactures and commercializes a suite of intravascular ultrasound (IVUS) and functional measurement (FM) products that enhance the diagnosis and treatment of vascular and structural heart disease. In Portfolio Grader’s specific subcategory of Earnings Momentum, VOLC also gets an F. The stock has a trailing PE Ratio of 39.60. For more information, get Portfolio Grader’s complete analysis of VOLC stock.

Slipping from C to a D rating, Hansen Medical (NASDAQ:HNSN) takes a hit this week. Hansen Medical develops and manufactures medical robotics designed for positioning, manipulation, and control of catheters and catheter-based technologies. The stock gets F’s in Equity and Cash Flow. As of Jan. 18, 2013, 15.3% of outstanding Hansen Medical shares were held short. To get an in-depth look at HNSN, get Portfolio Grader’s complete analysis of HNSN stock.

OraSure Technologie’s (NASDAQ:OSUR) rating falls this week to an F (“strong sell”), down from last week’s D (“sell”). OraSure Technologies develops, manufactures, and markets medical devices and diagnostic products. The stock also gets an F in Equity. For a full analysis of OSUR stock, visit Portfolio Grader.

The rating of CONMED Corp. (NASDAQ:CNMD) declines this week from C to a D. Conmed is a medical technology company that emphasizes surgical devices and equipment for minimally invasive procedures and monitoring. The stock also gets an F in Margin Growth. The stock currently has a trailing PE Ratio of 176.90. For more information, get Portfolio Grader’s complete analysis of CNMD stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.

Article printed from InvestorPlace Media,

©2021 InvestorPlace Media, LLC